TERRENCE A DUFFY, the Chairman and CEO of $CME, sold 13,089 shares of the company on 12-11-2025 for an estimated $3,522,249. We received data on the trade from a recent SEC filing. This was a sale of approximately 14.4% of their shares of this class of stock. Following this trade, they now own 77,715 shares of this class of $CME stock.
$CME Insider Trading Activity
$CME insiders have traded $CME stock on the open market 14 times in the past 6 months. Of those trades, 4 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:
- TERRENCE A DUFFY (Chairman and CEO) has made 0 purchases and 2 sales selling 25,000 shares for an estimated $6,738,815.
- SUNIL CUTINHO (Chief Information Officer) has made 0 purchases and 2 sales selling 11,896 shares for an estimated $3,229,444.
- DEREK SAMMANN (Sr MD Gl Hd Commodities Mkts) has made 0 purchases and 2 sales selling 7,200 shares for an estimated $1,984,798.
- HAROLD EUGENE JR. FORD sold 1,000 shares for an estimated $263,530
- JONATHAN L MARCUS (Sr MD General Counsel) has made 0 purchases and 2 sales selling 768 shares for an estimated $200,072.
- WILLIAM R SHEPARD has made 4 purchases buying 541 shares for an estimated $145,007 and 0 sales.
- TIMOTHY FRANCIS MCCOURT (Sr MD Global Head Equity & FX) sold 379 shares for an estimated $98,475
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CME Hedge Fund Activity
We have seen 782 institutional investors add shares of $CME stock to their portfolio, and 803 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SANDERS CAPITAL, LLC added 3,726,755 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,006,931,933
- JPMORGAN CHASE & CO removed 2,744,851 shares (-22.3%) from their portfolio in Q3 2025, for an estimated $741,631,291
- STRIVE ASSET MANAGEMENT, LLC added 2,355,701 shares (+inf%) to their portfolio in Q3 2025, for an estimated $636,486,853
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,998,425 shares (+63.5%) to their portfolio in Q3 2025, for an estimated $539,954,450
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,605,469 shares (+27.9%) to their portfolio in Q3 2025, for an estimated $433,781,669
- BLACKROCK, INC. added 1,222,646 shares (+4.1%) to their portfolio in Q3 2025, for an estimated $330,346,722
- VONTOBEL HOLDING LTD. removed 990,738 shares (-33.9%) from their portfolio in Q3 2025, for an estimated $267,687,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CME Revenue
$CME had revenues of $1.5B in Q3 2025. This is a decrease of -2.95% from the same period in the prior year.
You can track CME financials on Quiver Quantitative's CME stock page.
$CME Congressional Stock Trading
Members of Congress have traded $CME stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 4 times. They made 2 purchases worth up to $30,000 on 08/11, 07/22 and 2 sales worth up to $30,000 on 11/13, 08/14.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CME Analyst Ratings
Wall Street analysts have issued reports on $CME in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 11/13/2025
- Morgan Stanley issued a "Overweight" rating on 10/23/2025
- Deutsche Bank issued a "Buy" rating on 10/23/2025
- Citigroup issued a "Buy" rating on 09/25/2025
- JP Morgan issued a "Underweight" rating on 09/25/2025
- Oppenheimer issued a "Outperform" rating on 07/24/2025
To track analyst ratings and price targets for $CME, check out Quiver Quantitative's $CME forecast page.
$CME Price Targets
Multiple analysts have issued price targets for $CME recently. We have seen 9 analysts offer price targets for $CME in the last 6 months, with a median target of $303.0.
Here are some recent targets:
- Benjamin Budish from Barclays set a target price of $304.0 on 12/12/2025
- Patrick Moley from Piper Sandler set a target price of $313.0 on 11/13/2025
- Brian Bedell from Deutsche Bank set a target price of $300.0 on 10/23/2025
- Alex Kramm from UBS set a target price of $280.0 on 10/23/2025
- Patrick Moley from Morgan Stanley set a target price of $314.0 on 10/23/2025
- Patrick O'Shaughnessy from Raymond James set a target price of $307.0 on 10/13/2025
- Christopher Allen from Citigroup set a target price of $300.0 on 09/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
